CSIMarket
Company Name or Ticker Symbol
Search for other Categories
 


Neurocrine Biosciences Inc  (NBIX)
Other Ticker:  
 
    Sector  Healthcare    Industry Biotechnology & Drugs
   Industry Biotechnology & Drugs
   Sector  Healthcare
 

NBIX's Revenue Growth by Quarter and Year

Neurocrine Biosciences Inc's Revenue results by quarter and year




NBIX Revenue (in millions $) FY 2018 FY 2017 FY 2016 FY 2015
IV Quarter December -196.58 94.52 - -
III Quarter September 151.76 60.77 - -
II Quarter June 96.91 6.34 - -
I Quarter March 71.09 - 15.00 19.77
FY   123.18 161.63 15.00 19.77



NBIX Revenue forth quarter 2018 Y/Y Growth Comment
Neurocrine Biosciences Inc in the forth quarter recorded of $ -196.58 millions.

Looking into forth quarter results within Biotechnology & Drugs industry 3 other companies have achieved higher Revenue growth. While Neurocrine Biosciences Inc' s Revenue no change of % ranks overall at the positon no. 47 in the forth quarter.




NBIX Revenue ( Y/Y Growth %) 2018
2017 2016 2015
IV Quarter December - - - -
III Quarter September 149.73 % - - -
II Quarter June 1428.55 % - - -
I Quarter March - - -24.13 % -
FY   -23.79 % 977.53 % -24.13 % -

Financial Statements
Neurocrine Biosciences Inc's forth quarter 2018 Revenue $ -196.58 millions NBIX's Income Statement
Neurocrine Biosciences Inc's forth quarter 2017 Revenue $ 94.52 millions Quarterly NBIX's Income Statement
New: More NBIX's historic Revenue Growth >>


NBIX Revenue (Quarter on Quarter Growth %)

2018
2017 2016 2015
IV Quarter December - 55.54 % - -
III Quarter September 56.6 % 858.52 % - -
II Quarter June 36.32 % - - -
I Quarter March -24.79 % - - -
FY (Year on Year)   -23.79 % 977.53 % -24.13 % -




Revenue forth quarter 2018 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #4
Healthcare Sector #8
Overall #47

Revenue Y/Y Growth Statistics
High Average Low
38.92 % 5.83 % -52.66 %
(Jun 30 2018)   (Dec. 30, 2013)
Revenue forth quarter 2018 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #4
Healthcare Sector #8
Overall #47
Revenue Y/Y Growth Statistics
High Average Low
38.92 % 5.83 % -52.66 %
(Jun 30 2018)   (Dec. 30, 2013)

Revenue by Quarter for the Fiscal Years 2015, 2016, 2017, 2018

Neurocrine Biosciences Inc's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
859.34 % 73.87 % -100 %
(Sep 30 2017)  


NBIX's IV. Quarter Q/Q Revenue Comment
IV. Quarter 2018 accomplishment of -196.58 millions by Neurocrine Biosciences Inc appear even less good considering the 151.76 millions in the third quarter.

Within Biotechnology & Drugs industry 11 other companies have achieved higher Revenue quarter on quarter growth. While Neurocrine Biosciences Inc's Revenue growth quarter on quarter, overall rank is 411.


Revenue Q/Q Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #12
Healthcare Sector #41
Overall #411
Revenue Q/Q Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #12
Healthcare Sector #41
Overall #411
Revenue Q/Q Growth Statistics
High Average Low
859.34 % 73.87 % -100 %
(Sep 30 2017)  


NBIX's IV. Quarter Q/Q Revenue Comment
Recent of -196.58 millions by Neurocrine Biosciences Inc come out even worse if you take a look at 151.76 millions in the previous quarter.

Within Biotechnology & Drugs industry 11 other companies have achieved higher Revenue quarter on quarter growth. While Neurocrine Biosciences Inc's Revenue growth quarter on quarter, overall rank is 411.


Neurocrine Biosciences Inc's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Dec 31 2018)
12 Months Ending
(Sep 30 2018)
12 Months Ending
(Jun 30 2018)
12 Months Ending
(Mar 31 2018)
12 Months Ending
(Dec 31 2017)
Cumulative Revenue 12 Months Ending $ 123.17 $ 414.27 $ 323.28 $ 232.71 $ 0.00
Y / Y Revenue Growth (TTM) - - - - -
Year on Year Revenue Growth Overall Ranking # # # # #
Seqeuential Revenue Change (TTM) -70.27 % 28.14 % 38.92 % - -
Seq. Revenue Growth (TTM) Overall Ranking # 47 # 169 # 116 # 0 # 0




Cumulative Revenue growth Comment


Neurocrine Biosciences Inc achieved highest trailing twelve month year on year Revenue growth. While overall Revenue growth ranking, remained unchanged compare to the previous quarter at no. .

Revenue TTM Q/Q Growth Statistics
High Average Low
38.92 %
5.83 %
-52.66 %
 

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall # 0

Revenue TTM Y/Y Growth Statistics
High Average Low
-52.66 %
-52.66 %
-52.66 %
(Dec. 30, 2013)  


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 4
Sector # 8
S&P 500 # 47
Cumulative Revenue growth Comment


Neurocrine Biosciences Inc achieved highest trailing twelve month year on year Revenue growth. While overall Revenue growth ranking, remained unchanged compare to the previous quarter at no. .

Revenue TTM Q/Q Growth Statistics
High Average Low
38.92 %
5.83 %
-52.66 %
 


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall # 0

Revenue TTM Y/Y Growth Statistics
High Average Low
-52.66 %
-52.66 %
-52.66 %
(Dec. 30, 2013)  


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 4
Sector # 8
S&P 500 # 47




Other Revenue Growth
Biotechnology & Drugs Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
NBIX's Revenue Growth Ratio versus Biotechnology & Drugs Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth
Revenue Growth for NBIX's Competitors
Revenue Growth for Neurocrine Biosciences Inc's Suppliers
Revenue Growth for NBIX's Customers

You may also want to know
NBIX's Annual Growth Rates NBIX's Profitability Ratios NBIX's Asset Turnover Ratio NBIX's Dividend Growth
NBIX's Roe NBIX's Valuation Ratios NBIX's Financial Strength Ratios NBIX's Dividend Payout Ratio
NBIX's Roa NBIX's Inventory Turnover Ratio NBIX's Growth Rates NBIX's Dividend Comparisons



Companies with similar Revenue no change for the quarter ending Dec 31 2018 within Healthcare SectorY/Y Change %Revenue for the quarter ending Dec 31 2018
Petmed Express Inc -0.07 %$ -0.070 millions
Inspiremd, Inc. -1.44 %$ -1.439 millions
Meridian Bioscience Inc -1.54 %$ -1.536 millions
Hca Healthcare, Inc. -1.78 %$ -1.784 millions
Bausch Health Companies Inc. -1.94 %$ -1.942 millions
Encision Inc -3.33 %$ -3.326 millions
Quest Diagnostics Inc -5.01 %$ -5.010 millions
Allergan Plc -5.70 %$ -5.696 millions
Allied Healthcare Products Inc -7.01 %$ -7.015 millions
Brookdale Senior Living Inc. -8.32 %$ -8.316 millions
Guardion Health Sciences, Inc. -9.52 %$ -9.519 millions
Procyon Corp -10.15 %$ -10.151 millions
Prestige Consumer Healthcare Inc. -10.79 %$ -10.791 millions
Dynatronics Corp -14.61 %$ -14.608 millions
Community Health Systems Inc -15.24 %$ -15.243 millions
Teva Pharmaceutical Industries Ltd -16.49 %$ -16.487 millions
Coherent Inc -19.77 %$ -19.771 millions
Neurometrix, Inc. -24.36 %$ -24.357 millions
Cambrex Corp -26.30 %$ -26.303 millions
Escalon Medical Corp. -28.50 %$ -28.500 millions
Organovo Holdings, Inc. -32.44 %$ -32.437 millions
Shineco, Inc. -40.69 %$ -40.689 millions
Fresenius Medical Care Ag & Co. Kgaa -44.03 %$ -44.029 millions
Gb Sciences Inc -45.43 %$ -45.430 millions
Alnylam Pharmaceuticals, Inc. -47.69 %$ -47.686 millions
Lannett Co Inc -57.70 %$ -57.697 millions
Redhawk Holdings Corp. -61.30 %$ -61.301 millions
Cellular Biomedicine Group, Inc. -62.59 %$ -62.589 millions
Halozyme Therapeutics Inc. -68.23 %$ -68.226 millions
American Cryostem Corp -78.60 %$ -78.602 millions


     
       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

PAYC's Profile

Stock Price

PAYC's Financials

Business Description

Fundamentals

Charts & Quotes

PAYC's News

Suppliers

PAYC's Competitors

Customers & Markets

Economic Indicators

PAYC's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2019 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday Data provided by Barchart and subject to terms of use. To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Stock Price, historical and current end-of-day data provided by eoddata. Intraday data delayed per exchange requirements. S&P/Dow Jones Indices (SM) from Barchart and Eoddata. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071